MRI-safe 3Dl intracardiac ultrasound catheter for cardiovascular intervention

用于心血管介入的 MRI 安全 3Dl 心内超声导管

• 批准号: 8639877
• 负责人: F. Levent Degertekin
• 金额: $ 68.33万
• 依托单位: GEORGIA INSTITUTE OF TECHNOLOGY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-02-07 至 2017-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8639877
• 关键词: 3-Dimensional; Address; Adult; Affect; Animal Model; Animals; Architecture; Atrial Heart Septal Defects; Beryllium; Biological; Caliber; Cardiac; Cardiomyopathies; Cardiovascular system; Catheterization; Catheters; Child; Childhood; Clinical; Clinical Trials; Code; Collaborations; Complex; Custom; Data; Denmark; Development; Devices; Diagnostic radiologic examination; Disease; Doctor of Philosophy; Effectiveness; Electronics; Engineering; Exposure to; Face; Frequencies; Future; Goals; Heart; Heart Diseases; Human; Image; In Vitro; Institution; Intervention; Left; Magnetic Resonance Imaging; Microfabrication; Miniaturization; National Heart, Lung, and Blood Institute; Operative Surgical Procedures; Outcome; Pathology; Patients; Performance; Phase; Phase I Clinical Trials; Population; Preclinical Testing; Procedures; Process; Radiation; Resources; Roentgen Rays; Route; Safety; Sampling; Scheme; Silicon; Structure; Symptoms; System; Systems Development; Technology; Testing; Time; Translating; Ultrasonography; United States National Institutes of Health; Universities; Ventricular Septal Defects; Work; auricular appendage; base; clinical application; design; image guided intervention; image processing; improved; in vitro testing; in vivo; microsystems; novel; operation; pre-clinical; preclinical evaluation; prototype; public health relevance; repaired; research clinical testing; software development; success; transmission process; valve replacement

DESCRIPTION (provided by applicant): Symptomatic adult and pediatric structural heart disease affects more than 2.9% of the US population, not including cardiomyopathies and rhythm disorders. Although nonsurgical approach is the preferred route for relief of symptoms, even common procedures such as atrial septal defect closure can be difficult, protracted, or unsuccessful because of limitations not only in available catheter devices but also because of inadequate image guidance. Current 2D and limited-volume 3D intracardiac ultrasound catheters do not provide suitable full-volume en face images to depict complex cardiac structures in real time, do not depict real-time navigation of catheters, and require adjunctive X-ray guidance. Miniaturization of ultrasound probes to provide uninterrupted real-time full-volume intra-procedural 3-dimensional en-face depiction of cardiac pathology and catheter devices would represent a dramatic advance in image-guided intervention. Further, design of a 3D ICE probe from inception to operate safely during MRI as well as during conventional X-ray would dramatically advance or even revolutionize the capabilities of transcatheter therapy by enabling completely radiation-free non-surgical catheter navigation. Our proposal aims to realize such a catheter, the 3D MRICE, based on the close collaboration of two groups at NHLBI and at Georgia Tech, and the unique resources available at the NIH Clinical Center for catheter fabrication, preclinical evaluation, and clinical trials. We use CMUT-on-CMOS technology and massive parallel RF data multiplexing to implement an ultra- miniature, single chip volumetric ultrasound imaging system while reducing the transmission line count by 50x compared with current technology. Implemented as a novel actively cooled catheter of MRI-compatible materials, our approach will produce a versatile intravascular 3D ICE catheter that can operate under conventional X-ray and MRI. The 3D MRICE and custom, GPU based real-time imaging system will be evaluated systematically through in-vitro and in-vivo studies with special emphasis on MRI safety leading to a an Phase I IDE clinical trial at the end of year 3. If successful, our work will address a key unmet need and fundamentally enhance image-guided catheter treatments of complex heart disease to improve effectiveness and outcome.

描述（由申请人提供）：有症状的成人和儿童结构性心脏病影响超过2.9%的美国人口，不包括心肌病和节律障碍。尽管非手术方法是缓解症状的首选途径，但即使是房间隔缺损关闭等常见手术也可能困难、拖延或不成功，这不仅是因为可用导管装置的限制，而且还因为图像引导不足。目前的2D和有限容积的3D心内超声导管不能提供合适的全容积正面图像来实时描绘复杂的心脏结构，不能描绘导管的实时导航，并且需要辅助的x线引导。超声探头小型化，可提供不间断的实时全容量术中心脏病理和导管设备的三维面描绘，将代表图像引导干预的巨大进步。此外，3D ICE探针的设计从一开始就可以在MRI和传统x射线期间安全操作，通过实现完全无辐射的非手术导管导航，将大大提高甚至彻底改变经导管治疗的能力。我们的提案旨在基于NHLBI和佐治亚理工学院两个小组的密切合作，以及NIH临床中心在导管制造，临床前评估和临床试验方面的独特资源，实现这样一种导管，3D MRICE。我们使用cmos上的cmos技术和大规模并行射频数据复用来实现一个超小型的单芯片体积超声成像系统，同时与现有技术相比，将传输线数量减少了50倍。作为一种新型的MRI兼容材料主动冷却导管，我们的方法将产生一种多功能的血管内3D ICE导管，可以在传统的x射线和MRI下操作。3D MRICE和定制的基于GPU的实时成像系统将通过体外和体内研究进行系统评估，特别强调MRI安全性，并在第三年底进行I期IDE临床试验。如果成功，我们的工作将解决一个关键的未满足的需求，并从根本上增强复杂心脏病的图像引导导管治疗，以提高有效性和结果。